SLC5A2
Results: 24
| # | Item |
|---|---|
21![April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes](https://www.pdfsearch.io/img/87473b344cec45eee3f71c72182f3422.jpg "April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes") | April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 DiabetesAdd to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2013-04-01 21:51:25 |
22 | July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received forAdd to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2014-07-04 01:18:30 |
23 | ANNEX I SUMMARY OF PRODUCT CHARACTERISTICSAdd to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2013-09-16 09:02:56 |
24 | PDF DocumentAdd to Reading ListSource URL: www.fkdb.netLanguage: German - Date: 2013-09-28 11:31:17 |